Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease—authors' reply

Ruben J. Colman, Phillip Minar

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)567-568
JournalAlimentary pharmacology & therapeutics
Volume57
Issue number5
DOIs
Publication statusPublished - 1 Mar 2023

Keywords

  • Adolescent
  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Humans
  • Inflammatory Bowel Diseases/drug therapy

Cite this